From the USA: Type 2 Diabetes Remission Maintained After RYGB Despite Weight Regain

Despite weight regain (WR), type 2 diabetes mellitus (T2DM) remission rates are generally maintained after Roux-en-Y gastric bypass (RYGB), according to research published online Feb. 13 in the Journal of the American College of Surgeons.

Omar M. Ghanem, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues conducted a retrospective review of patients who underwent successful primary RYGB or sleeve gastrectomy (SG) with a body mass index ≥35 kg/m2 and preoperative diagnosis of T2DM. The rates of continued diabetes remission (CDR) were stratified into WR quartiles and compared after selecting the optimal procedure for glycemic control.

Source: Advances and More licensed by HealthDay

https://advancesandmore.com/advances_article.htm?id=N2RkMTkxMDQtNjM0Yi00ZDg3LWIyMTktMTVkMDEzZmMzOGY2&client=Nw%3D%3D&section=undefined